4574 Taiko Pharmaceutical
- 347
- +7+2.06%
Taiko Pharmaceutical News
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Prior Span B Tokyo Stock Exchange Prime ＜3031＞ Raccoon HD 653 621.75 651 ＜7380＞ 16 FG 4560 4546.25 4280 ＜7581＞ Saizeriya 5280 4937.5 5212.5 ＜9692＞ CEC 1717 170
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1873＞ Japan House HD 337 361 ＜2882＞ Eat and 1983 2046 ＜3288＞ Open H 4919 5054 ＜3387＞ Kriles HD 1045 1070 ＜3501＞ Suminoe Textile
Taiko Pharmaceutical Raises FY Net View to Y550.00M
GROUP New Forecast Prior For Year To Dec 2024 Forecast Revenue Y6.80 bln Y6.80 bln Operating Profit Y410.00 mln
Taiko Pharmaceutical Sees FY Net Y350.00M
Taiko Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Dec 2024 Revenue Y6.80 bln Operating Profit Y410.00 mln Pre
Taiko Pharmaceutical FY Loss Y3.61B Vs Loss Y4.90B
Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan Year Ended December 31 GROUP 2023 2022 Revenue Y6.12 bln Y5.04 bln Operating Profit (Y1.01 bln
Taiko Pharmaceutical 9-Mos Loss Y562.00M Vs Loss Y3.18B
Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan Nine Months Ended September 30 GROUP 2023 2022 Revenue Y4.42 bln Y3.39 bln Operating Profit
Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical
Kingworld Medicines Group (HKG:1110) subsidiary Kingworld Medicines Health Management purchased an additional 1,007,500 shares in Japan-based Taiko Pharmaceutical (TYO:4574) at 338.58 yen per share, a
Jinhuo Pharmaceutical Group (01110.HK): Further subscription for shares in Taiko Pharmaceutical
On August 16, 2023, Goldwell Pharmaceutical Group (01110.HK) issued an announcement. On August 15, 2023, Jinhuo Pharmaceutical, a wholly-owned subsidiary of the company, placed an order with the distribution agent. Based on this, Jinhuo Pharmaceutical agreed to subscribe for an additional 1.075 million Taiko shares at a cost of 338.58 yen (equivalent to about HK$18.35) per share of Taiko Shares (accounting for about 2.08% of Taiko Pharmaceutical's issued share capital as of the date of this announcement, excluding Taiko Pharmaceutical After completion, according to the subscription details
Taiko Pharmaceutical 1H Loss Y514.00M Vs Loss Y2.80B
Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan 1st Half Ended June 30 GROUP 2023 2022 Revenue Y2.49 bln Y1.86 bln Operating Profit (Y396.
Taiko Pharmaceutical 1Q Loss Y243.00M Vs Loss Y1.75B
Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan 1st Quarter Ended March 31 GROUP 2023 2022 Revenue Y1.17 bln Y621.00 mln Operating Profi
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical
04:50 AM EDT, 04/25/2023 (MT Newswires) -- Kingworld Medicines Group (HKG:1110) is subscribing to 2.2 million shares in Taiko Pharmaceutical (TYO:4574) for 832.1 million yen, according to a Monday fil
Taiko Pharmaceutical to Pay 607 Million Yen Penalty; Shares Down 3%
06:42 AM EDT, 04/12/2023 (MT Newswires) -- Taiko Pharmaceutical (TYO:4574) was fined 607.4 million yen by Japan's Consumer Affairs Agency on Tuesday for baselessly claiming that its Cleverin sanitizer
Taiko Pharmaceutical Sees FY Net Y50.00M
Taiko Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Dec 2023 Revenue Y7.90 bln Operating Profit Y532.00 ml
Taiko Pharmaceutical FY Loss Y4.90B Vs Loss Y9.59B
Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan Year Ended December 31 GROUP 2022 2021 Revenue Y5.04 bln Y11.30 bln Operating Profit (Y3.
Taiko Pharmaceutical 9-Mos Loss Y3.18B Vs Loss Y1.95B
Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan Nine Months Ended September 30 GROUP 2022 2021 Revenue Y3.39 bln Y8.36 bln Operating Profit (Y
Analysis
Price Target
No Data
